LENSAR, Inc.
LENSAR, Inc. (LNSR) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · LNSR · as of Jun 9, 2026
Key Statistics
Explore LENSAR, Inc. Data
lnsr stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 3 · Buy rate: 66.7%
The LNSR analyst consensus is Buy, based on ratings from 3 Wall Street analysts over the past 3 months. The average 12-month price target is $10.00, representing +78.57% upside from the current price of $5.60.
Competitors & Peers
lnsr competitorsLNSR
ANIK
ARAY
AVR
CRBP
CRDFStock Performance
Full HistoryAbout LENSAR, Inc.
LENSAR, Inc. is an established medical device company that specializes in the development and commercialization of an advanced femtosecond laser system. This innovative technology is designed for the …
what is lensar, inc. · lnsr stock overview · lensar, inc. company profile · who is lensar, inc. ceo · lnsr NASDAQ · lensar, inc. headquarters · lensar, inc. business segments
About Stock Overview & Key Data
LENSAR, Inc. (LNSR) is a Healthcare company in the Medical - Devices industry, listed on NASDAQ since Oct 2, 2020. As of the latest trading session, LNSR stock price is $5.60, with a market capitalization of $67.8M. The stock has returned -56.84% over the past 12 months and -51.42% year-to-date.
According to 3 Wall Street analysts, the consensus rating for LENSAR, Inc. stock is Buy, with an average 12-month price target of $10.00. In fiscal year 2025, LENSAR, Inc. reported revenue of $58.4M and net income of -$34.3M. For detailed data — including LENSAR, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, LENSAR, Inc. (LNSR) stock price is $5.60. The stock is traded on NASDAQ under the ticker symbol LNSR. The 52-week range is $5.06 – $13.47.